After decades of decline, rates of rectal cancer have risen by about 1 percent each year from 2018 to 2022. Rectal cancer, which originates in the last 12 to 15 centimeters of the large intestine, now ...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today reported financial results for the three ...
Colorectal cancer is the third most common cancer in the United States. Although screening has led to a decrease in incidence ...
March is Colorectal Cancer Awareness Month, and doctors are reminding people that screening can help detect the disease early.
New research links increased risk factors to alcohol consumption, ultra-processed foods and other disruptions to the gut microbiome. The Tampa Bay Times is hosting a free community conversation, in ...
The gut microbiome at time of surgery may significantly impact recurrence of colorectal cancer.An analysis of nearly 300 ...
Dr. Eric Winer, director of the Yale Cancer Center, said in “younger people in general there’s a higher proportion that have ...
ImmunityBio (NASDAQ: IBRX) recently announced a partnership with Accord Healthcare to expand European access to ANKTIVA for bladder cancer patients across 33 countries. ANKTIVA achieved a 71% complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results